Position in GPCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,142,474
-$2,468,074 QoQ
Shares Held
168,931
+10.7% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GPCR Over Time
Shares Held
Position Value (USD)
Derivatives in GPCR
reported options exposure · as of Dec 31, 2024CallValue
$6,346,080
CallShares
234,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,570,822,033 across 342 Biotechnology names. GPCR ranks #129 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in GPCR
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,142,474 | 168,931 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,610,548 | 152,560 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $35,687,428 | 1,274,551 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $25,303,940 | 1,220,055 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $13,677,652 | 790,159 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $20,367,472 | 751,013 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $6,346,080 | 234,000 | Call | Sole | 2025-02-14 | |
| 2024-09-30 | $9,173,010 | 209,000 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $40,003,584 | 911,451 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,239,775 | 82,500 | Call | Sole | 2024-08-14 | |
| 2024-06-30 | $44,739,996 | 1,139,292 | Shares | Sole | 2024-08-14 | |
| 2024-06-30 | $1,515,822 | 38,600 | Put | Sole | 2024-08-14 | |
| 2024-03-31 | $3,897,774 | 90,942 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $683,504 | 16,769 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $366,840 | 9,000 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $2,853,200 | 70,000 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | $15,119,647 | 299,874 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,838,474 | 44,226 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $843,569 | 35,459 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||